DocGo No Longer Emerging Growth Company, Faces Stricter SEC Rules

Ticker: DCGO · Form: 8-K · Filed: Jan 16, 2024 · CIK: 1822359

Docgo INC. 8-K Filing Summary
FieldDetail
CompanyDocgo INC. (DCGO)
Form Type8-K
Filed DateJan 16, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulatory-change, compliance, corporate-governance

TL;DR

**DocGo is no longer an emerging growth company, meaning more SEC rules and higher costs.**

AI Summary

DocGo Inc. filed an 8-K on January 16, 2024, indicating that it is not an emerging growth company. This matters to investors because emerging growth companies benefit from reduced reporting requirements, and DocGo's status change means it will now face stricter SEC scrutiny and increased compliance costs, potentially impacting its financial performance and transparency for shareholders.

Why It Matters

This change means DocGo will incur higher compliance costs and face more rigorous reporting requirements, which could affect its profitability and operational focus. Investors should be aware of the increased regulatory burden.

Risk Assessment

Risk Level: medium — The transition from an emerging growth company status typically increases compliance costs and regulatory scrutiny, posing a moderate financial and operational risk.

Analyst Insight

Investors should research the implications of DocGo's transition from an emerging growth company, specifically focusing on potential increases in compliance costs and how this might affect future earnings reports and operational efficiency.

Key Players & Entities

FAQ

What is the primary purpose of DocGo Inc.'s 8-K filing on January 16, 2024?

The primary purpose of DocGo Inc.'s 8-K filing on January 16, 2024, is to report that the company is no longer an emerging growth company, as indicated by the unchecked box for 'emerging growth company' status.

What is DocGo Inc.'s trading symbol and on which exchange is its common stock registered?

DocGo Inc.'s trading symbol is DCGO, and its common stock, with a par value of $0.0001 per share, is registered on The Nasdaq Stock Market LLC.

What is the address of DocGo Inc.'s principal executive offices?

The address of DocGo Inc.'s principal executive offices is 35 West 35th Street, Floor 6, New York, New York 10001.

What is DocGo Inc.'s state of incorporation and IRS Employer Identification Number?

DocGo Inc.'s state of incorporation is Delaware, and its I.R.S. Employer Identification No. is 85-2515483.

Does this 8-K filing indicate any simultaneous satisfaction of filing obligations under other provisions, such as Rule 425 under the Securities Act?

No, the 8-K filing explicitly indicates that it is not intended to simultaneously satisfy filing obligations under Rule 425 under the Securities Act, Rule 14a-12 under the Exchange Act, Rule 14d-2(b) under the Exchange Act, or Rule 13e-4(c) under the Exchange Act, as all corresponding boxes are unchecked.

Filing Stats: 556 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-01-16 07:42:04

Key Financial Figures

Filing Documents

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On January 16, 2024, DocGo Inc. issued a press release responding to a report released by Fuzzy Panda Research, a short seller (the "Press Release"). The Press Release includes, among other things, select preliminary financial results for fiscal year 2023. The Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report").

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. The information set forth in Item 2.02 of this Current Report is incorporated into this Item 7.01 by reference. The information in Item 2.02 and this Item 7.01 of this Current Report, including Exhibit 99.1, is being furnished, and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 1 6 , 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DOCGO INC. By: /s/ Norman Rosenberg Name: Norman Rosenberg Title: Chief Financial Officer and Treasurer Date: January 16, 2024 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing